ImmuCell Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ImmuCell Stock Summary

ImmuCell competes with Transgene, Alpha Cognition, Fennec Pharmaceuticals, Lipella Pharmaceuticals, and Eliem Therapeutics. ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine. Immucell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 64 people.

ImmuCell Key Financial Ratios

ImmuCell Key Balance Sheet Accounts

ImmuCell Key Income Statement Accounts

ImmuCell Key Cash Accounts

ImmuCell Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ImmuCell's current stock value. Our valuation model uses many indicators to compare ImmuCell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ImmuCell competition to find correlations between indicators driving ImmuCell's intrinsic value. More Info.ImmuCell is rated fourth overall in return on equity category among its peers. It also is rated fourth overall in return on asset category among its peers . At present, ImmuCell's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ImmuCell's earnings, one of the primary drivers of an investment's value.

ImmuCell Systematic Risk

Today, most investors in ImmuCell Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ImmuCell's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ImmuCell growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ImmuCell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ImmuCell. We use our internally-developed statistical techniques to arrive at the intrinsic value of ImmuCell based on widely used predictive technical indicators. In general, we focus on analyzing ImmuCell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ImmuCell's daily price indicators and compare them against related drivers.

When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.